MANK

COM:MANKINDPHARMA

Mankind Pharma

  • Stock

INR

Last Close

2,551.60

25/11 09:40

Market Cap

848.24B

Beta: -

Volume Today

358.29K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
10.41B
-
14.72B
41.35%
16.45B
11.73%
15.41B
6.29%
average payables
7.06B
-
8.72B
23.46%
10.42B
19.57%
10.56B
1.28%
average receivables
5.20B
-
7.12B
37.11%
book value per share
87.00
-
117.88
35.48%
153.65
30.35%
185.61
20.80%
239.04
28.79%
capex per share
-5.69
-
-7.80
37.00%
-58.55
651.01%
-20.77
64.53%
9.54
145.95%
capex to depreciation
-2.30
-
-2.63
14.07%
-14.08
436.24%
-2.55
81.86%
0.96
137.60%
capex to operating cash flow
-0.21
-
-0.27
28.86%
-2.55
828.58%
-0.47
81.72%
0.18
138.10%
capex to revenue
-0.04
-
-0.05
29.30%
-0.30
499.76%
-0.10
68.43%
0.04
138.87%
cash per share
27.07
-
50.04
84.86%
31.94
36.18%
38.16
19.49%
28.17
26.19%
days of inventory on hand
170.63
-
236.71
38.73%
260.12
9.89%
104.22
59.93%
173.48
66.46%
days payables outstanding
141.40
-
133.40
5.66%
159.06
19.24%
68.72
56.79%
123.17
79.22%
days sales outstanding
25.57
-
29.96
17.19%
debt to assets
0.03
-
0.04
46.38%
0.10
152.73%
0.02
82.18%
0.02
3.63%
debt to equity
0.04
-
0.05
35.72%
0.14
178.31%
0.02
84.34%
0.02
5.76%
dividend yield
0.01
-
earnings yield
0.02
-
0.02
22.43%
0.03
12.37%
0.02
11.78%
0.02
8.19%
enterprise value
568.81B
-
570.49B
0.30%
575.46B
0.87%
568.41B
1.23%
924.37B
62.62%
enterprise value over ebitda
35.27
-
31.97
9.35%
27.53
13.87%
29.24
6.20%
32.90
12.52%
ev to operating cash flow
53.17
-
50.16
5.66%
62.57
24.72%
31.85
49.09%
42.95
34.83%
ev to sales
9.70
-
9.18
5.34%
7.40
19.44%
6.50
12.09%
8.94
37.57%
free cash flow per share
21.01
-
20.59
2.00%
-35.59
272.83%
23.78
166.81%
44.19
85.83%
free cash flow yield
0.01
-
0.01
2.00%
-0.03
272.83%
0.02
166.81%
0.02
14.33%
graham net net
3.30
-
27.12
721.89%
-16.78
161.85%
17.12
202.04%
3.84
77.56%
graham number
227.18
-
292.59
28.79%
354.11
21.03%
365.56
3.23%
501.13
37.08%
income quality
0.74
-
0.67
9.64%
0.47
30.71%
1.39
198.88%
1.13
19.18%
intangibles to total assets
0.01
-
0.01
32.72%
0.21
3,266.60%
0.19
10.62%
0.14
24.00%
interest coverage
69.05
-
86.28
24.95%
34.48
60.04%
38.53
11.76%
142.90
270.83%
interest debt per share
3.81
-
6.49
70.13%
23.19
257.30%
5.17
77.70%
5.61
8.42%
inventory turnover
2.14
-
1.54
27.92%
1.40
9.00%
3.50
149.59%
2.10
39.92%
invested capital
0.04
-
0.05
35.72%
0.14
178.31%
0.02
84.34%
92.70B
417,247,557,319,233.25%
market cap
569.76B
-
569.76B
0%
569.76B
0%
569.76B
0%
926.12B
62.55%
net current asset value
14.21B
-
23.97B
68.74%
15.75B
34.27%
22.61B
43.53%
41.81B
84.89%
net debt to ebitda
-0.06
-
0.04
169.77%
0.27
563.01%
-0.07
125.34%
-0.06
10.03%
net income per share
26.36
-
32.28
22.43%
36.27
12.37%
32.00
11.78%
47.75
49.23%
operating cash flow per share
26.70
-
28.39
6.31%
22.96
19.12%
44.55
94.02%
53.73
20.61%
payables turnover
2.58
-
2.74
6.00%
2.29
16.13%
5.31
131.44%
2.96
44.20%
receivables turnover
14.28
-
12.18
14.67%
research and ddevelopement to revenue
0.02
-
0.00
88.56%
return on tangible assets
0.21
-
0.20
2.83%
0.20
1.88%
0.16
19.17%
0.19
14.92%
revenue per share
146.42
-
155.13
5.95%
194.25
25.22%
218.25
12.35%
257.99
18.21%
roe
0.30
-
0.27
9.63%
0.24
13.80%
0.17
26.96%
0.20
18.50%
roic
0.31
-
0.26
16.59%
0.20
21.47%
0.17
17.32%
0.35
107.97%
sales general and administrative to revenue
0.01
-
0.01
33.42%
0.02
32.98%
0.22
-
shareholders equity per share
87.00
-
117.88
35.48%
153.65
30.35%
185.61
20.80%
233.73
25.93%
stock based compensation to revenue
0.00
-
tangible asset value
36.25B
-
48.24B
33.06%
44.22B
8.33%
58.50B
32.31%
78.93B
34.91%
tangible book value per share
90.50
-
120.41
33.06%
110.38
8.33%
146.04
32.31%
197.03
34.91%
working capital
15.64B
-
25.53B
63.29%
17.83B
30.15%
24.65B
38.21%
44.48B
80.49%

All numbers in INR (except ratios and percentages)